Using emibetuzumab directed towards MET for the treatment of lung cancer

David Ross Camidge, MD, PhD of the University of Colorado, Denver, CO, provides an insight into emibetuzumab, a monoclonal antibody directed towards the mesenchymal-to-epithelial transition (MET) fact... Author: VJOncology Added: 08/18/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts